🔍 Explore the Archive
Filter 1+ documents by question, dataset, type, and investigative value. Combine filters to build your investigation lens.
Active:
P24: Cross-Case Patterns ✕
V13: Physical Evidence ✕
D5: Procedural Violations ✕
D1: Who Benefits ✕
Clear all
unknown
DataSet-9
EFTA00586577
EFTA00586577.pdf
OH2 LaboratoriesRe-engineering Drug Discovery
Company Overview
February 2015
David Levy, Ph.D.
General Manager and Chairman
…
V13
D5
P24
D1
P22